|
Index of reports
> Cases resulting in a serious event (47)
Below is the selection of adverse event reports related to Estratest (Esterified Estrogens) that includes cases resulting in a serious event.
Reports 1 - 25 of 47 Next >>
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Ovarian Cancer
Suspect drug(s):
Estraderm
Estratest
Premarin
Adverse event in 48 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: female
Adverse reactions / side effects: Ovarian Cancer
Suspect drug(s):
Estraderm
Estratest
Premarin
Adverse event in 48 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-10-30
Patient: 48 year old female, weighing 108.0 kg (237.7 pounds)
Adverse reactions / side effects: Weight Decreased, Breast Cancer, Depression
Suspect drug(s):
Estrace
Dosage: oral
Administration route: Oral
Indication: Anxiety
Start date: 1995-06-01
Estratest
Indication: Anxiety
Start date: 1983-05-21
End date: 1984-03-01
Premarin
Dosage: 1.25mg daily, oral
Administration route: Oral
Indication: Anxiety
Start date: 1984-03-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Estratest
Medroxyprogesterone
Premarin
Prempro
Provera
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-29
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Conjugated Estrogens
Cycrin
Dosage: unknown
Indication: Hormone Replacement Therapy
Estrace
Estratest
Dosage: unknown
Indication: Hormone Replacement Therapy
Medroxyprogesterone Acetate
Dosage: unknown
Indication: Hormone Replacement Therapy
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Premphase 14 / 14
Dosage: unknown
Indication: Hormone Replacement Therapy
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Provera
Dosage: unknown
Indication: Hormone Replacement Therapy
Unspecified Estrogen Replacement Therapy
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-10-25
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Cycrin
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2004-11-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2004-11-01
Medroxyprogesterone Acetate
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2004-11-01
Premarin
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2004-11-01
Prempro
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2004-11-01
Provera
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1989-01-01
End date: 2004-11-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female, weighing 77.2 kg (169.8 pounds)
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Cycrin
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Estratest
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Estrogen NOS
Medroxyprogesterone Acetate
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Premarin
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Provera
Dosage: unspecified
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 2000-01-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-24
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Adverse event resulted in: hospitalization
Suspect drug(s):
Cenestin
Estratest
Medroxyprogesterone Acetate
Premarin
Prempro
Indication: Menopausal Symptoms
Provera
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-10-23
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Cycrin
Dosage: oral
Administration route: Oral
Start date: 1989-01-01
End date: 2004-11-01
Estratest
Dosage: oral
Administration route: Oral
Start date: 1989-01-01
End date: 2004-11-01
Medroxyprogesterone
Dosage: oral
Administration route: Oral
Start date: 1996-01-01
End date: 2004-11-01
Premarin
Dosage: oral
Administration route: Oral
Start date: 1989-01-01
End date: 2004-11-01
Prempro
Dosage: oral
Administration route: Oral
Start date: 1989-01-01
End date: 2004-11-01
Provera
Dosage: oral
Administration route: Oral
Start date: 1989-01-01
End date: 2004-11-01
Adverse event in receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient:
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estratest
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2001-07-01
End date: 2001-10-01
Norethindrone Acetate
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 1994-01-01
End date: 1997-01-01
Prempro
Dosage: unspecified
Administration route: Oral
Indication: Hormone Replacement Therapy
Start date: 2000-12-01
End date: 2001-07-01
Prempro
Dosage: unspecified dose regimen
Administration route: Oral
Start date: 2001-10-01
End date: 2003-10-01
Provera
Dosage: unspecified
Indication: Hormone Replacement Therapy
Start date: 1997-01-01
End date: 2000-12-01
Provera
Dosage: unspecified
Administration route: Oral
Start date: 2001-07-01
End date: 2001-10-01
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-16
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estratest
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 2000-03-01
End date: 2002-03-01
Premarin
Dosage: unknown
Indication: Oestrogen Replacement Therapy
Start date: 1999-05-01
End date: 2000-02-01
Prempro
Dosage: unknown
Indication: Hormone Replacement Therapy
Start date: 1998-01-01
End date: 1999-05-01
Adverse event in 74 year old female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-08
Patient: 74 year old female
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Cycrin
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estraderm
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratab
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Ogen
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Prempro
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-10-08
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estrace
Estratest
Estrogens
Prempro
Provera
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a physician from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Benign Intracranial Hypertension
Suspect drug(s):
Estratest (Esterified Estrogens)
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-10-02
Patient: female
Adverse reactions / side effects: Breast Cancer Metastatic
Suspect drug(s):
Estratest
Prempro
Indication: Hormone Replacement Therapy
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-07-31
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Adverse event resulted in: death
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Estratest
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Premarin
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Provera
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1995-01-01
End date: 2000-01-01
Adverse event in 74 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-27
Patient: 74 year old female
Adverse reactions / side effects: Abdominal Pain, Narcolepsy, Osteoporosis, Wrist Fracture, Pain, Fall, HIP Surgery, Asterixis, Breast Cosmetic Surgery, Emphysema, Breast Pain, Breast Cancer, Haemorrhoids, Breast Mass, Renal Cyst, Axillary Mass, HIP Fracture, Myoclonus, Dysarthria, Diverticulum, Limb Injury, Radical Mastectomy, Gastrointestinal Disorder, Benign Neoplasm of Thyroid Gland, Arteriosclerosis Coronary Artery, Sleep Apnoea Syndrome, Wrist Surgery
Suspect drug(s):
Combipatch
Indication: Menopausal Symptoms
Start date: 2000-01-01
End date: 2003-01-01
Estratest
Indication: Menopause
Premarin
Provera
Other drugs received by patient: Toprol-XL; Hydrochlorzide; Norvasc; Plaquenil; Allegra; Lipitor
Adverse event in 48 year old female receiving Estratest (Esterified Estrogens)
Reported by a consumer/non-health professional from United States on 2007-07-26
Patient: 48 year old female
Adverse reactions / side effects: Breast Cancer Stage II
Suspect drug(s):
Estrace
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Estraderm
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Estratest
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Premarin
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Provera
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 1993-01-01
End date: 1998-01-01
Other drugs received by patient: Zoloft
Adverse event in 55 year old female receiving Estratest (Esterified Estrogens)
Reported by a physician from United States on 2007-07-11
Patient: 55 year old female, weighing 62.1 kg (136.6 pounds)
Adverse reactions / side effects: Breast Cancer
Adverse event resulted in: hospitalization
Suspect drug(s):
Activella
Indication: Hormone Replacement Therapy
Start date: 2001-06-01
End date: 2002-06-01
Estratest
Indication: Hormone Replacement Therapy
Start date: 1999-11-01
End date: 2002-06-01
Prempro
Dosage: 0.625 mg / 2.5 mg
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2001-06-01
Other drugs received by patient: Medroxyprogesterone Acetate; Provera; Estrace; Estring; Serzone; Effexor XR; Xanax
Adverse event in 66 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-10
Patient: 66 year old female, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Pyrexia, Macrognathia, Vaginal Disorder, Smear Cervix Abnormal, Mammogram Abnormal, Colonic Polyp, Coeliac Disease, Irritable Bowel Syndrome, Bone Density Decreased, Temperature Intolerance, Cough, Breast Cancer, Pneumonia, Vaginal Discharge, Breast Mass, Cataract Operation, Meniere's Disease, Temporomandibular Joint Syndrome, Vision Blurred, Platelet Count Decreased, Gastric Polyps, Lactose Intolerance, Restless Legs Syndrome, Thrombocythaemia, Blood Thyroid Stimulating Hormone Increased, Hepatitis, Hypokalaemia, Pleural Effusion, Genital Disorder Female, Blood Cholesterol Increased, Depression, Injury, Gastrooesophageal Reflux Disease, Loss of Libido, Cataract, Breast Disorder, Hepatic Enzyme Increased, Anxiety, Mucosal Inflammation, Oral Pain, Epigastric Discomfort, Mastectomy, Hypothyroidism, Hypertension
Adverse event resulted in: hospitalization
Suspect drug(s):
Aygestin
Combipatch
Indication: Menopause
Start date: 1991-01-01
Combipatch
Dosage: 0.25 mg, unk
Start date: 2000-01-01
End date: 2000-01-01
Estraderm
Dosage: 0.05 mg, unk
Indication: Menopause
Start date: 1994-12-01
End date: 2002-01-01
Estratest
Estrogenic Substance
Ogen
Indication: Menopause
Oragest
Indication: Menopause
Premarin
Premarin
Indication: Menopause
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Premarin
Start date: 1990-01-01
End date: 1992-01-01
Prempro
Provera
Dosage: 5 mg for 14 days every other month
Indication: Menopause
Start date: 1995-08-01
End date: 1995-09-01
Vivelle
Dosage: 0.05 mg, unk
Indication: Menopause
Adverse event in female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-07-06
Patient: female
Adverse reactions / side effects: Breast Cancer Female
Suspect drug(s):
Cycrin
Dosage: oral
Administration route: Oral
Estradiol
Dosage: oral
Administration route: Oral
Estratest
Dosage: oral
Administration route: Oral
Medroxyprogesterone Acetate
Dosage: oral
Administration route: Oral
Premarin
Dosage: oral
Administration route: Oral
Prempro
Dosage: oral
Administration route: Oral
Adverse event in 57 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-05
Patient: 57 year old female, weighing 68.0 kg (149.7 pounds)
Adverse reactions / side effects: Tooth Extraction, Neck Injury, Skin Burning Sensation, Breast Cancer in Situ, Malignant Breast Lump Removal, Rash, Biopsy, Biopsy Site Unspecified Abnormal, Erythema, Skin Reaction, Hot Flush, Road Traffic Accident, Depression, Bone Density Decreased, Ligament Sprain
Suspect drug(s):
Combipatch
Indication: Menopause
Start date: 2002-11-14
End date: 2002-12-31
Estrace
Estratest
Oral Contraceptive NOS
Dosage: unk, unk
Administration route: Oral
Start date: 1965-01-01
End date: 1972-01-01
Prempro
Indication: Menopause
Start date: 1996-01-01
End date: 1999-01-01
Provera
Indication: Menopause
Start date: 1999-06-01
End date: 2005-03-01
Other drugs received by patient: Tamoxifen Citrate; Arimidex
Adverse event in 62 year old female receiving Estratest (Esterified Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-07-02
Patient: 62 year old female, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Polyp Colorectal, Mammogram Abnormal, Fibrocystic Breast Disease, Intervertebral Disc Disorder, Postmenopausal Haemorrhage, Breast Microcalcification, Blood Cholesterol Increased, Benign Breast Neoplasm, Breast Hyperplasia, Breast Cancer, Tonsillectomy, Abscess Drainage, Mastitis, Radiotherapy, Malignant Breast Lump Removal, Appendicitis, Anal Fissure, Haematochezia, Hysterectomy, Uterine Dilation and Curettage, Colonoscopy Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Cycrin
Start date: 1999-01-01
Estrace
Dosage: unk, qhs
Start date: 1999-01-01
Estraderm
Start date: 1989-01-01
Estratest
Start date: 1990-01-01
End date: 1999-01-01
Premarin
Dosage: 0.625 unk, unk
Administration route: Oral
Start date: 1989-01-01
Prempro
Indication: Menopause
Start date: 1999-04-01
End date: 2002-04-01
Provera
Dosage: 10 mg, unk
Start date: 1989-01-01
Other drugs received by patient: Steroids NOS; Oxygen Therapy; Lotrel; Cardizem
Adverse event in 51 year old female receiving Estratest (Esterified Estrogens)
Reported by a lawyer from United States on 2007-06-12
Patient: 51 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Breast Cancer
Suspect drug(s):
Climara
Indication: Menopausal Symptoms
Estrace
Indication: Menopausal Symptoms
Estradiol
Indication: Menopausal Symptoms
Estratest
Indication: Menopausal Symptoms
Premarin
Indication: Menopausal Symptoms
Progesterone
Indication: Menopausal Symptoms
Provera
Indication: Menopausal Symptoms
Page 1 Next >>
|
